RESUMO
BACKGROUND: The treatment of facial telangiectasia include microsclerotherapy, laser, and electrosurgery. It is important that the treatment for telangiectasia be relatively risk-free, especially avoiding unsightly scarring. OBJECTIVE: We evaluated the effectiveness, complications, and recurrence rate of patients with facial telangiectasia treated with microsclerotherapy using osmotic sclerosing agent. In addition, we also evaluated the associated factors, the sites of predilection, and types of facial telangiectasia. PATIENTS AND METHODS: Fifteen patients with facial telangiectasia were treated with microsclerotherapy using osmotic sclerosant(Sclerodex(R)). The procedure was performed at 4 week intervals and on average 2 times. The effectiveness was evaluated by the comparison of photographs monthly during mean 6 months follow-up period. RESULTS: Mean improvement rate was 70% and partial recurrence was observed in 3 cases(20%). Transient bruising(33%), transient pigmentation(7%) and telangiectatic matting(7%) were observed as complications. CONCLUSION: Sclerotherapy with osmotic sclerosant(Sclerodex(R)) is safe and moderately effective; because it usually has more than a good response and minimal complications.